⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL711772 | 1.00 | — | — | |
| SCHEMBL8010941 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL29068663 | 0.97 | — | — | |
| Ethylene Glycol SCHEMBL11328339 | 0.92 | TDP1 (0.38) | — | |
| SCHEMBL3399729 | 0.83 | TSHR (0.44) | — | |
| SCHEMBL3399731 | 0.83 | TSHR (0.44) | — | |
| SCHEMBL3805346 | 0.80 | — | — | |
| SCHEMBL5881401 | 0.78 | GRIK1 (0.37) | — | |
| SCHEMBL7123743 | 0.78 | GRIK1 (0.37) | — | |
| SCHEMBL13001269 | 0.78 | GRIK1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11407726-B2 | Using stereoretention for the stereoselective formation of e-macrocycles with Ru-based olefin metathesis catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2022-08-09 | — | — | US | disclosed |
| US-20200385360-A1 | USING STEREORETENTION FOR THE STEREOSELECTIVE FORMATION OF E-MACROCYCLES WITH RU-BASED OLEFIN METATHESIS CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2020-12-10 | — | — | US | disclosed |
| US-20160324826-A1 | METHOD FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | HAWKING BIOLOGICAL TECHNOLOGY CO., LTD. (TW) | 2016-11-10 | — | — | US | disclosed |
| US-20160324826-A1 | METHOD FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | HAWKING BIOLOGICAL TECHNOLOGY CO., LTD. (TW) | 2016-11-10 | — | — | US | disclosed |
| US-20160272858-A1 | TWO-COMPONENT LAMINATION ADHESIVE OF RENEWABLE ORIGIN | BOSTIK SA (FR) | 2016-09-22 | — | — | US | disclosed |
| EP-2917256-B1 | TWO-COMPONENT LAMINATION ADHESIVE OF RENEWABLE ORIGIN | BOSTIK SA (FR) | 2016-09-07 | — | — | EP | disclosed |
| EP-2992879-A1 | PHARMACEUTICAL COMPOSITION FOR INHIBITING AUTOPHAGY OF MOTOR NEURONS AND USE THEREOF | China Medical University (TW) | 2016-03-09 | — | — | EP | disclosed |
| US-20160023200-A1 | COMPLEX CATALYSTS BASED ON AMINO-PHOSPHINE LIGANDS FOR HYDROGENATION AND DEHYDROGENATION PROCESSES | GOUSSEV DMITRI (US) | 2016-01-28 | — | — | US | disclosed |
| US-20140271568-A1 | METHOD AND KIT FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | Hawking Biological Technology Co., Ltd (TW) | 2014-09-18 | — | — | US | disclosed |
| US-20140271568-A1 | METHOD AND KIT FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | Hawking Biological Technology Co., Ltd (TW) | 2014-09-18 | — | — | US | disclosed |
| WO-2009106621-A1 | METHOD FOR PRODUCING OLEFINICALLY SATURATED CARBONYL COMPOUNDS BY OXIDATIVE DEHYDROGENATION OF ALCOHOLS | BASF SE (DE) | 2009-09-03 | — | — | WO | disclosed |
| WO-2009030649-A2 | METHOD FOR PRODUCING TEDA DERIVATIVES | BASF SE (DE) | 2009-03-12 | — | — | WO | disclosed |
| US-20070129327-A1 | Blood flow promoters for cauda equina tissues | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-6107526-A | Process for producing ethyl tertiary butyl ether | UOP LLC (US) | 2000-08-22 | — | — | US | disclosed |
| US-5859244-A | EXHIBIT VASODILATING ACTIVITY BASED ON CALCIUM ANTAGONISM AND PLATELET-ACTIVATING FACTOR ANTAGONISM | FUJIREBIO, INC. (JP) | 1999-01-12 | — | — | US | disclosed |
| US-5763614-A | VASODILATION BASED ON CALCIUM ANTAGONISM AND PAF ANTAGONISM | FUJIREBIO INC. (JP) | 1998-06-09 | — | — | US | disclosed |
| US-5696268-A | REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT | FUJIREBIO INC. (JP) | 1997-12-09 | — | — | US | disclosed |
| US-5644059-A | REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT | FUJIREBIO INC. (JP) | 1997-07-01 | — | — | US | disclosed |
| US-5367081-A | Vasodilator, antiallergen | FUJIREBIO INC. (JP) | 1994-11-22 | — | — | US | disclosed |
| EP-0488345-A1 | 1,4-Dihydropyridine derivatives and methods of producing the same | FUJIREBIO INC. (JP) | 1992-06-03 | — | — | EP | disclosed |